Cure My Disease

Don't miss your cure!

 Log in / Sign up

New screening tool aims to break the silence on sexual health after childhood cancer

NCT ID NCT05524610

Diagnosis Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a simple questionnaire to help doctors identify sexual health concerns in teenagers and young adults who have or had childhood cancer. The goal is to improve communication between patients and providers. About 205 participants aged 15-24 will use the screening tool during clinic visits, and researchers will measure whether it leads to more discussions about sexual function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sexual function screening questionnaire (PROMIS SexFS Brief)
What this could lead to
If successful, this screening approach could become a standard way for doctors to identify and discuss sexual health issues with young cancer survivors, leading to better support and quality of life.
What could go wrong
This is a small, early-stage study focused on feasibility and communication, not on treating sexual dysfunction. The screening tool may not work well in all clinic settings or for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 205 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2023

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 24 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Provision to sign and date the consent form. 2. Stated willingness to comply with all study procedures and be available for the duration of the study. 3. Be aged 15-24 years old at the time of enrollment 4. Patients with or surviving of cancer (must be found in the International Classification of Diseases for Oncology (ICD-O) and have a behavior code ≥2) 5. Must have received cancer-directed therapy with at least one of the following: * Chemotherapy: any anticancer drug to treat the cancer diagnosis including immunotherapy * Radiotherapy: any radiotherapy to treat the cancer diagnosis * Surgery: any surgery to remove cancer including partial or total resections. Biopsies are not considered surgery. 6. Cancer must have been diagnosed before the age of 18 years 7. Patient must have an appointment at one of four clinical sites: CHCO HOPE Survivorship Program, CHCO Oncology Clinic, CHCO Neuro-Oncology Clinic, Seattle Children's Hospital Survivorship Program Exclusion Criteria An individual who meets any of the following criteria will be excluded from participation in this study: 1. Unable to read and speak English 2. Patients who did not receive cancer-directed therapy 3. Insufficient cognitive functioning to complete study measures, as determined by patient's 4. Participation in intervention development 5. Patient is at end of life or on hospice, as determined by primary oncologist 6. Patients who did not undergo sexual function screening within 1 month of being due will be excluded from implementation outcomes measurement 7. Patient is at end of life or on hospice, as determined by primary oncologist

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatric cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pediatric cancer Survivorship

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Childrens Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Colorado Hospital

    RECRUITING

    Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.